CAS No. |
137076-50-7 |
|---|---|
中文名称 |
1,4,7,10-四(乙氧羰基甲基)-1,4,7,10-四氮杂环十二烷 |
英文名称 |
1,4,7,10-Tetrakis(ethoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane |
别名 |
ethyl 2-[4,7,10-tris(2-ethoxy-2-oxoethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;1,4,7,10-Tetrakis(ethoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane;DOTAET;1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, 1,4,7,10-tetraethyl ester;DOTAEt137076-50-7;1,4,7,10-Tetrakis(ethoxycarbonylmethyl)-1,4,7,10-tetraazacyc;tetraethyl 2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetate;Doxorubicin Impurity 70 Hydrochloride |
标准英文名 |
tetraethyl 2,2',2'',2'''-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrayl)tetraacetate |
MDL No. |
MFCD09263313 |
分子式 |
C24H44N4O8 |
分子量 |
516.64 |
精确分子量 |
516.32 |
SMILES |
O=C(CN1CCN(CC(OCC)=O)CCN(CC(OCC)=O)CCN(CC(OCC)=O)CC1)OCC |
标准SMILES |
CCOC(=O)CN1CCN(CC(=O)OCC)CCN(CC(=O)OCC)CCN(CC(=O)OCC)CC1 |
用途 |
It is a DOTA-based metal chelating agent capable of binding radionuclides for the preparation of radiopharmaceutical conjugates (RDCs); RDCs possess the ability to specifically target biomolecules and can be used in medical imaging or therapy. |
InChIKey |
SHXTUKRRXWXLMI-UHFFFAOYSA-N |
|
|
评论 |
|---|